Earlier this year, Metagenomi had the spotlight with a $93.7 million IPO. Now, Moderna is exiting stage left on a partnership ...

Moderna MRNA will report first-quarter 2024 results on May 2, before the opening bell. In the last reported quarter, the ...

Moderna’s stock got a boost on Tuesday after positive data was released from a trial of a form of head-and-neck cancer.

This story was written by Markets Insider's RoboEddy, which automatically writes these stories based on data provided by our partners. Moderna NewsMORE Related Stocks Indices Commodities Currencies ...

According to some new data revealed by Moderna (NASDAQ: MRNA) at the American Association for Cancer Research Annual Meeting ...

The U.S. Food and Drug Administration (FDA) is set to issue a decision on the company's respiratory syncytial virus (RSV) ...

"People literally talk about how AI is going to cure diseases someday, and I think this is a very meaningful first step," ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present data from its respiratory portfolio, including ...

Generative AI will help advance Moderna’s broad and diverse portfolio to maximize the Company’s impact on patients ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from ...

Moderna began a collaboration with OpenAI in early 2023 with the launch of Moderna's own instance of ChatGPT, called mChat.

CHESAPEAKE, Va. (WAVY) — The Chesapeake Fire Department responded to a fire at NextEra Energy Solar Farm in Southern ...